Feedback / Questions
ABD-147 - Abdera Therap
https://www.businesswire.com/news/home/20250825455176/en/Abdera-Therapeutics-to-Present-Early-Pharmacokinetics-Dosimetry-and-Safety-Data-from-Ongoing-Phase-1-Trial-of-ABD-147-at-the-IASLC-2025-World-Conference-on-Lung-Cancer-and-Participate-in-Upcoming-Investor-Conferences
Aug 26, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next